BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19282459)

  • 1. Cancer in dyskeratosis congenita.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Blood; 2009 Jun; 113(26):6549-57. PubMed ID: 19282459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
    Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
    Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
    Vlachos A; Rosenberg PS; Atsidaftos E; Alter BP; Lipton JM
    Blood; 2012 Apr; 119(16):3815-9. PubMed ID: 22362038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology?
    Rackley S; Pao M; Seratti GF; Giri N; Rasimas JJ; Alter BP; Savage SA
    Psychosomatics; 2012; 53(3):230-5. PubMed ID: 22458992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence in persons with Fanconi anemia.
    Rosenberg PS; Greene MH; Alter BP
    Blood; 2003 Feb; 101(3):822-6. PubMed ID: 12393424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to androgen therapy in patients with dyskeratosis congenita.
    Khincha PP; Wentzensen IM; Giri N; Alter BP; Savage SA
    Br J Haematol; 2014 May; 165(3):349-57. PubMed ID: 24666134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.
    Tsilou ET; Giri N; Weinstein S; Mueller C; Savage SA; Alter BP
    Ophthalmology; 2010 Mar; 117(3):615-22. PubMed ID: 20022637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.
    Tamary H; Nishri D; Yacobovich J; Zilber R; Dgany O; Krasnov T; Aviner S; Stepensky P; Ravel-Vilk S; Bitan M; Kaplinsky C; Ben Barak A; Elhasid R; Kapelusnik J; Koren A; Levin C; Attias D; Laor R; Yaniv I; Rosenberg PS; Alter BP
    Haematologica; 2010 Aug; 95(8):1300-7. PubMed ID: 20435624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.
    Imai J; Suzuki T; Yoshikawa M; Dekiden M; Nakae H; Nakahara F; Tsuda S; Mizukami H; Koike J; Igarashi M; Yabe H; Mine T
    Intern Med; 2016; 55(23):3441-3444. PubMed ID: 27904106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
    Vulliamy TJ; Knight SW; Mason PJ; Dokal I
    Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
    Deeg HJ; Socié G; Schoch G; Henry-Amar M; Witherspoon RP; Devergie A; Sullivan KM; Gluckman E; Storb R
    Blood; 1996 Jan; 87(1):386-92. PubMed ID: 8547667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.